Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[18/12/2020 | 20:01]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZLoJwtUSZVXmv5iau1Fg6fae5G0LBVEf-2F9ykVgi6=
TaTUTQcaer1qQoM4QpAc6LO-2FvtXXVCt6V-2B5gdN_xDPID0vOuylFAU8fv4e60wei4JxqEGBd=
VWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9=
c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2Fe3Zqc=
mHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXELHkDhwUg4QReX2HBV75Ue8OV97VlEXFiUu=
MjPihSG6ERDO-2FEyrUAC-2Fqy4tO7bk5Dkv76CVIewUdHasWmG4QNvwXWCTGsooZAXIIfxJToU=
fvE-2BQNbcnmAX1hOncBcYOgqI6UQv3gaJ84NdKt823b4Cs-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 18 December 2020 =E2=80=93 20:00 (CET) =E2=80=93 regula=
ted information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB=C2=A0SA/NV (=E2=80=9CUCB=E2=80=9D or =
the =E2=80=9CCompany) (Euronext Brussels: UCB)=C2=A0announces that, followi=
ng exercises of stock options by members of its personnel, it has disposed =
of UCB shares OTC in view of deliveries of these shares to the relevant mem=
bers of the personnel, within the framework of the Long Term Incentive Prog=
ram of the UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZLoJwtUSZVMUu-2FUmWhcYJdVZTDd0UURnd-2B-2BQ=
z5VelYdJpXl-2F-2FCx9jRjbauQHUOj3TcqGK-2Fj16DXlgi_xDPID0vOuylFAU8fv4e60wei4J=
xqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj=
-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2=
Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEKpUSiIba4k9rj2BIr7R4cDHEJToz=
KYHGfFUplcBEcIAe9vdNq-2Bxc-2BbJlx4nNzMu3v0Jz8uX6t8PlQsUQpnTPCwGjduuTQmkvBxt=
w6uUKkr3m7ivkAjvQEz-2FIfLaJVJRexvwmEf7hRbaE9iC9QNIA8g-3D
=C2=A0
This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the=
following link. (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM=
8iDZJQyQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSz=
xYKNx18dK5MiuQ-3D-3DaSfk_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46=
DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0=
FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY=
5uUrzDmuDR7aY4BHnSNHCXEAyS9FpgCGagyvxh5Krk2wutXSho0t-2FHoomXZw8vjwcnfwhpigY=
XPjbuQUo4ZL9G48Pq34VrnQyIJdZ2HtLFBOYatlyhq2gLN5rF0LUc7HrOMr8BKyWDZKRgj5dQf3=
CGKi6-2BEcuQOk35G3z37V2Re24-3D
=C2=A0
Investor Relations

Antje Witte,
Investor Relations, UCB
T +32 2 559 94 14,
antje.witte@ucb.com
=C2=A0
Isabelle Ghellynck,
Investor Relations, UCB
T +32 2 559 95 88,
isabelle.ghellynck@ucb.com

About UCB

UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/ls/cl=
ick?upn=3DTeZUXWpUv-2B6TCY38pVLo9iNXQpOzOpqt-2BlzP11Y08Xg-3DZBYH_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6=
-2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEA0pn38VZEU19=
3Ah-2FzuINg37bBCTpYZ6SO2NsqDLDF4Al4JjlhhpVUj7RSwk3ZFWamjEKO8OvcV7tQbVXOkpAz=
jkrGA4EtG6X7ubSxNOorfLogMd6LKJeG6Q-2Frbp5ft8C5TLgYgUQuLhKMZ-2B4UYHle0-3D ) =
is a global biopharmaceutical company focused on the discovery and developm=
ent of innovative medicines and solutions to transform the lives of people =
living with severe diseases of the immune system or of the central nervous =
system. With 7 500 people in approximately 40 countries, the company genera=
ted revenue of =E2=82=AC 4.9 billion in 2019. UCB is listed on Euronext Bru=
ssels (symbol: UCB). Follow us on Twitter: @UCB_news

Image
Disposals of own shares - 18 December 2020 (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4Gxn=
tdZLoJwtUSZVMUu-2FUmWhcYJdVZTDd0UURlgNYNA9uzABixHA72ppGcw-3DJ3P9_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6=
-2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXECyGkVVNrf-2F=
snqBzB3z97urepD4n6-2F0r08I1xg-2BJ6MtoGHVL-2BKyBIm633hnaOBZcArQ1UtOtb2g2pn1l=
pknpAdlYeapYYVbIfrD8fybHLb-2BDhcq8cAuczw3W1BHXck83Ujvq2NcQ4Zj1oVZQ81e71KA-3=
D GenericFile
201218 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4Gxntd=
ZLoJwtUSZVyEoBKLuTNDESvlv6GWdbS3o4oI5YuqDAAETZhLrMoJc-3DqZZr_xDPID0vOuylFAU=
8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO=
eoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Bt=
iy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEL11cIlvdHgc3zer8=
7Vy5VWEFwCyK1LP-2FowqROt-2FzMJJUBSynXNAEqgmwxLeQEvfHUk6OvzHf-2FGGxpWxg-2F28=
zBJ9rwEKETv5nHo0l51fduOg3mRvDhhmC4a74Yn3mNUxlRwNMzmHkTeIZEu2jNdGm8w-3D Gene=
ricFile
201218 - Alie nation d actions propres (https://u7061146.ct.sendgrid.net/ls=
/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZL=
oJwtUSZVFLGg41JAcl779ZZfVLmJAADKZFXQpGIaikSAesZx7ps-3Djqnn_xDPID0vOuylFAU8f=
v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo=
COG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy=
0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEJy-2B2cdG3QsFcpf5U=
-2B8pdtHjJuXBFrSsyuZ4IyXXnJS3sT2g-2FMgYQjRJF9M22x9YmBImO3-2BGyP6qXQbEt0-2FM=
HJKxJcF-2BwUD-2BgS-2FwgAncIkoLRe2CTrJdISRPrpYyYRVxcMWh1AWLbyjhAUbCkQjAxgs-3=
D GenericFile
201218 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZLoJwtUS=
ZVrrizOV07nmF1TGp0864SWMpnEVOkZLEQshLi7qeidEg-3DiVLe_xDPID0vOuylFAU8fv4e60w=
ei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ek=
ocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp6=
6Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEMOM9Q4P-2FqrMZQYuIzyXThx=
X8G8CLwq138gSbY40JVVL2pMj-2FdtnGFy6c-2BfmQh1CR2RuxJCJtA6uz1DzN29a-2FgghrtB-=
2BEFD-2FwAfikndP1QVj2xPPogZYcc8yi4HrIrb6zTg4r01F53PYEpBZq7bGWNs-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXIybRz7z5dgwCHzuKR3kpSWMy7UPrY8D=
fAijpvKvlbkKjbYC4cwHeWfIZFsrOvRVJilDa87EjyXjMBdu72I9kBMm7f46S5yYS9lH0UKdZRU=
M-3D-_sM_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EF=
aZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl=
0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BH=
nSNHCXEDal-2BazqB0sbAk8VShelJCzo7o-2BnwqRTW-2FQaz91-2B17O7SrocWopSsQeZMEOMQ=
pF7fLAjUxzLc0Dy-2BVcYBNEO1fbr54MpfWTLmpDWtIPm-2FmyMIlhxySqZiI6pvkNNGAK60Eth=
RdkfbV5e2IdAI7Vi3kY-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=